Page 55 - CIBEREHD2016-ENG

Most relevant scientific articles
• Bujanda L., Rodriguez-Gonzalez A., Sarasqueta C., Eizaguirre E., Hijona E., Marin J.J.G. et al. Effect of pravastatin on the survival of patients with advanced gastric cancer. Oncotarget. 2016;7(4):4379-4384.
• Banales J.M., Cardinale V., Carpino G., Marzioni M., Andersen J.B., Invernizzi P. et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology and Hepatology. 2016;13(5):261-280.
• Quintero E., Carrillo M., Leoz M.-L., Cubiella J., Gargallo C., Lanas A. et al. Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study. PLoS Medicine. 2016;13(5).
• D’Agnolo H.M.A., Kievit W., Takkenberg R.B., Riano I., Bujanda L., Neijenhuis M.K. et al. Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial. Journal of Hepatology. 2016.
• Cubiella J., Vega P., Salve M., Diaz-Ondina M., Alves M.T., Quintero E. et al. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients. BMC Medicine. 2016;14(1).
Hightlights
Dr. Luis Bujanda is the President of the Spanish Association of Gastroenterology since March 2016. Our group coordinates the “European Network for the Study of Cholangiocarcinoma (ENSCCA: www.enscca.org)”, composed by 30 groups / research centers in the European Union and 7 in USA. In 2016 received the “EASL Registry Award “ by the European Association for the Study of the Liver (EASL) for create a European database of patients with cholangiocarcinoma (CCA), which will contain clinical information as well as biological samples. The groups of the Oncology Area –CIBEREHD also participating, for example, Jordi Bruix (Hospital Clinic), Bruno Sangro (CUN) and José Juan Garcia Marin (IBSAL).
On the other hand, our group organized in May 2016 the “I International Congress of CCA” in San Sebastian). In addition, our group participates in the “International Registry of Polycystic Liver Diseases” (EASL Registry Award 2014) and in the Spanish Registry of Liver Metabolic Diseases (HEPAMET). Our group also participates in the first international GWAS study on CCA
(http://cholangiocarcinoma.org /professionals/action-alert-mayo-clinic-study/)
In addition, Dr. Bañales is the Editor of 40 manuscripts for a “Special Issue in Cholangiocytes in Health and Disease” for BBA- molecular basis of disease (1Q).
EHD
research Groups 55